Expression, purification, and refolding of the myeloid inhibitory receptor leukocyte immunoglobulin-like receptor-5 for structural and ligand identification studies

Protein Expression and Purification

Volumn 47, Issue 2, 2006, Pages 490-497

  Garner, Lee I ^a   Salim, Mahboob ^a   Mohammed, Fiyaz ^a   Willcox, Benjamin E ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Dendritic cells; Inhibitory; LIR 5; Refolding

Indexed keywords

IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 5, HUMAN; LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR 5, HUMAN; LIGAND; LILRB1 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; DENDRITIC CELL; ESCHERICHIA COLI; GEL CHROMATOGRAPHY; GENE; HUMAN; IMMUNOLOGICAL TOLERANCE; ISOLATION AND PURIFICATION; METABOLISM; MULTIGENE FAMILY; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; SURFACE PLASMON RESONANCE;

ANTIGENS, CD; CHROMATOGRAPHY, GEL; DENDRITIC CELLS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; GENES, MHC CLASS I; HUMANS; IMMUNE TOLERANCE; LIGANDS; MULTIGENE FAMILY; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY, PROTEIN; SURFACE PLASMON RESONANCE;

ESCHERICHIA COLI; PROKARYOTA;

EID: 33646576257     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2005.11.020     Document Type: Article

References (25)

1. Wende H., Colonna M., Ziegler A., and Volz A. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. Mamm. Genome 10 (1999) 154-160
2. Martin A.M., Kulski J.K., Witt C., Pontarotti P., and Christiansen F.T. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol. 23 (2002) 81-88
3. Cella M., Nakajima H., Facchetti F., Hoffmann T., and Colonna M. ILT receptors at the interface between lymphoid and myeloid cells. Curr. Top. Microbiol. Immunol. 251 (2000) 161-166
4. Borges L., and Cosman D. LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev. 11 (2000) 209-217
5. Samaridis J., and Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur. J. Immunol. 27 (1997) 660-665
6. Cosman D., Fanger N., Borges L., et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7 (1997) 273-282
7. Chapman T.L., Heikema A.P., West Jr. A.P., and Bjorkman P.J. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 13 (2000) 727-736
8. Willcox B.E., Thomas L.M., Chapman T.L., Heikema A.P., West Jr. A.P., and Bjorkman P.J. Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18. BMC Struct. Biol. 2 (2002) 6
9. Nakajima H., Samaridis J., Angman L., and Colonna M. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. J. Immunol. 162 (1999) 5-8
10. Chapman T.L., Heikema A.P., and Bjorkman P.J. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral MHC homolog UL18. Immunity 11 (1999) 603-611
11. Shiroishi M., Tsumoto K., Amano K., et al. Human inhibitory receptors ILT2 and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 100 (2003) 8856-8861
12. Willcox B.E., Thomas L.M., and Bjorkman P.J. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 4 (2003) 913-919
13. Cella M., Dohring C., Samaridis J., et al. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 185 (1997) 1743-1751
14. Chang C.C., Ciubotariu R., Manavalan J.S., et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3 (2002) 237-243
15. O'Callaghan C.A., Byford M.F., Wyer J.R., et al. BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. Anal. Biochem. 266 (1999) 9-15
16. Willcox B.E., Gao G.F., Wyer J.R., et al. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 10 (1999) 357-365
17. Willcox B.E., Gao G.F., Wyer J.R., et al. Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand binding. Protein Sci. 8 (1999) 2418-2423
18. Garboczi D.N., Hung D.T., and Wiley D.C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89 (1992) 3429-3433
19. Snyder G.A., Brooks A.G., and Sun P.D. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. Proc. Natl. Acad. Sci. USA 96 (1999) 3864-3869
20. Reddy K.R., Lilie H., Rudolph R., and Lange C. l-Arginine increases the solubility of unfolded species of hen egg white lysozyme. Protein Sci. 14 (2005) 929-935
21. Brown M.H., Preston S., and Barclay A.N. A sensitive assay for detecting low-affinity interactions at the cell surface reveals no additional ligands for the adhesion pair rat CD2 and CD48. Eur. J. Immunol. 25 (1995) 3222-3228
22. Altman J.D., Moss P.A., Goulder P.J., et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94-96
23. Brown M.H., Boles K., van der Merwe P.A., Kumar V., Mathew P.A., and Barclay A.N. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 188 (1998) 2083-2090
24. Braud V.M., Allan D.S., O'Callaghan C.A., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391 (1998) 795-799
25. Wright G.J., Puklavec M.J., Willis A.C., et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13 (2000) 233-242